drug

lamotrigine

1 story · latest Aug 5, 2026

Status: FDA approved Dec 1994 · NDA020241, NDA020764, NDA022115, NDA022251, NDA022509, NDA218879
Brands: Lamictal, Lamictal Cd, Lamictal Odt, Lamictal Xr, Subvenite
Trials: 1 registered trial in coverage

Relationships

Developed by GlaxoSmithKline

Developed by Owp Pharmaceuticals, INC

Timeline

Amneal wins two labeling supplement approvals for extended-release Lamotrigine ANDA

Aug 5Regulatory decisionAmneal Pharmaceuticals, LLC lamotrigine

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.